Menu
Sign In Search Podcasts Libraries Charts People & Topics Add Podcast API Blog Pricing

Tim Doyle

πŸ‘€ Speaker
1184 total appearances

Appearances Over Time

Podcast Appearances

Equity Mates Investing Podcast
The Inside Story of Eucalyptus: Tim Doyle on Starting, Scaling and Selling a $1.6 billion business

The interesting last one was about advertising.

Equity Mates Investing Podcast
The Inside Story of Eucalyptus: Tim Doyle on Starting, Scaling and Selling a $1.6 billion business

We cop a lot of grief for essentially advertising weight loss.

Equity Mates Investing Podcast
The Inside Story of Eucalyptus: Tim Doyle on Starting, Scaling and Selling a $1.6 billion business

And I, I find it really, it's, it's kind of a challenging idea.

Equity Mates Investing Podcast
The Inside Story of Eucalyptus: Tim Doyle on Starting, Scaling and Selling a $1.6 billion business

Cause like, obviously you have this problem, which is like promoting, uh, like body standards or any, like there is like a lot of dark parts of advertising thinness or in any way, it's gotta be very, very careful, but also these things are transformational for people's health.

Equity Mates Investing Podcast
The Inside Story of Eucalyptus: Tim Doyle on Starting, Scaling and Selling a $1.6 billion business

And so if you, you like have some sense of responsibility to be like, Hey, like these things aren't going to kill you and you can do it in a safe and effective way and you'll be happier and healthier.

Equity Mates Investing Podcast
The Inside Story of Eucalyptus: Tim Doyle on Starting, Scaling and Selling a $1.6 billion business

And like a lot of people are.

Equity Mates Investing Podcast
The Inside Story of Eucalyptus: Tim Doyle on Starting, Scaling and Selling a $1.6 billion business

Um, and so if walking that line, um,

Equity Mates Investing Podcast
The Inside Story of Eucalyptus: Tim Doyle on Starting, Scaling and Selling a $1.6 billion business

you end up getting a lot of criticism, which comes from people who have never really struggled with their weight.

Equity Mates Investing Podcast
The Inside Story of Eucalyptus: Tim Doyle on Starting, Scaling and Selling a $1.6 billion business

And so they're like seeing pressure to lose weight through advertising as like a huge societal negative, which I understand, but there is also a huge societal positive, which is like people who have transforming experiences on these medications and on our programs, you know, have a better life.

Equity Mates Investing Podcast
The Inside Story of Eucalyptus: Tim Doyle on Starting, Scaling and Selling a $1.6 billion business

And so you're walking that line is some criticism is really valid and you have to take it on board, but then there's so much of it that is like bad, poorly thought through and bad faith that you have to like get quite a thick skin to kind of push through and understand that you're doing the right thing.

Equity Mates Investing Podcast
The Inside Story of Eucalyptus: Tim Doyle on Starting, Scaling and Selling a $1.6 billion business

Definitely.

Equity Mates Investing Podcast
The Inside Story of Eucalyptus: Tim Doyle on Starting, Scaling and Selling a $1.6 billion business

Yeah, that was definitely part of the criticism.

Equity Mates Investing Podcast
The Inside Story of Eucalyptus: Tim Doyle on Starting, Scaling and Selling a $1.6 billion business

I think like.

Equity Mates Investing Podcast
The Inside Story of Eucalyptus: Tim Doyle on Starting, Scaling and Selling a $1.6 billion business

Yeah.

Equity Mates Investing Podcast
The Inside Story of Eucalyptus: Tim Doyle on Starting, Scaling and Selling a $1.6 billion business

And it's an interesting societal question because like we go to big lengths to not advertise medication and we have to do that.

Equity Mates Investing Podcast
The Inside Story of Eucalyptus: Tim Doyle on Starting, Scaling and Selling a $1.6 billion business

But a medical program, which is kind of what we offer, the question then is like, how do you talk about that without like, I guess, like at least insinuating that there is medication involved?

Equity Mates Investing Podcast
The Inside Story of Eucalyptus: Tim Doyle on Starting, Scaling and Selling a $1.6 billion business

And you might take the view that like, well, there should be no advertising at all for any product that involves medicine.

Equity Mates Investing Podcast
The Inside Story of Eucalyptus: Tim Doyle on Starting, Scaling and Selling a $1.6 billion business

But the counterfactual there is there's a lot of negative media coverage of these medicines.

Equity Mates Investing Podcast
The Inside Story of Eucalyptus: Tim Doyle on Starting, Scaling and Selling a $1.6 billion business

So people, they get a stigma that is unwarranted.

Equity Mates Investing Podcast
The Inside Story of Eucalyptus: Tim Doyle on Starting, Scaling and Selling a $1.6 billion business

I think like AstraZeneca vaccine is another example of this.